Article
[Exon skipping therapy for Duchenne muscular dystrophy by using antisense Morpholino].
Rinsho shinkeigaku = Clinical neurology - 1 Nov 2009
Takeda Shin'ichi
Abstract excerpt
Duchenne muscular dystrophy (DMD) is caused by the lack of dystrophin protein at the sarcolemma. Exon skipping by antisense oligonucleotides is a novel method to restore the reading frame of the mutated DMD gene, and rescue dystrophin production. We recently reported that systemic delivery of Morpholino antisense oligonucleotides targeting exon 6 and 8 of the canine DMD gene, efficiently recovered functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
